The specificity of CD8 ϩ T cell responses can vary dramatically between primary and secondary infections. 
Introduction
The CD8 ϩ T cell responses to respiratory virus infections tend to be highly focused in terms of antigen specificity (1) . In the case of influenza virus infection of mice, CD8 ϩ T cell responses are typically directed at only a handful of specific epitopes. And in a particularly extreme example, the entire CD8 ϩ T cell response to a mouse parainfluenza virus (Sendai virus) is directed at a single epitope (2, 3) . The highly focused nature of CD8 ϩ T cell responses to pathogens indicates that individual epitopes differ in their capacity to induce T cell responses (4) . Indeed, depending on their relative contributions to the total T cell response, individual epitopes can be classified as dominant, codominant, or subdominant, thereby establishing an immunodominance hierarchy. Interestingly, the immunodominance status of any given epitope is generally only a relative, rather than intrinsic, characteristic. Thus, elimination of a dominant epitope from a pathogen usually results in the elevation of a previously subdominant epitope to a dominant status (4, 5) . Such a switch in T cell specificity does not necessarily affect the magnitude of the total CD8 T cell response, suggesting that epitope immundominance does not directly regulate the extent of T cell expansion.
Understanding immunodominance patterns is critical for the development of effective vaccines designed to promote cellular immunity. Therefore, substantial effort has been directed at identifying dominant epitopes and understanding the mechanisms that regulate dominance hierarchies. These studies have identified several factors that appear to determine the immunodominance hierarchy of MHC class I-restricted epitopes. The most important factor appears to be the density of antigen that is effectively presented on antigen-presenting cells. Antigen density is controlled by the relative efficiency of distinct antigen processing steps such as route of antigen acquisition, protease/proteosome degra-Impact of Differential Antigen Processing on CD8 ϩ T Cells dation, transport into the endoplasmic reticulum and the affinity of the peptide for class I molecules (or its ability to form stable peptide/class I complexes; references [5] [6] [7] [8] [9] [10] [11] [12] . The complexity of the T cell repertoire also influences immunodominance and epitope selection in the course of an infection (13) . Thus, some epitopes may be subdominant if the number of T cells available to respond to that epitope is especially low.
Recently, it has been shown that T cell immunodominance patterns can differ substantially between primary and secondary responses to infection (14) (15) (16) . For example, Belz et al. (15) have demonstrated a substantial shift in the relative contributions of T cells specific for two major epitopes, nucleoprotein (NP 366-374 /D b ) and acidic polymerase (PA 224-233 /D b ), between the primary and secondary response in influenza virus-infected C57BL/6 mice. Whereas T cells specific for both of these epitopes are present in equivalent numbers in the lung during the primary response to influenza virus infection, T cells specific for the NP 366-374 /D b epitope dominate the secondary response (15, 16) . In this report, we investigated the mechanism underlying this changing pattern of immunodominance after influenza virus infection. The data show that the NP 366 
Materials and Methods
Viruses, Animals, and Infections. The Enders strain of Sendai virus and influenza virus A/HK-x31 (x31, H3N2) and A/PR8/ 34 (PR8, H1N1) were grown, stored, and titrated as described previously (13, 17) . Female C57BL/6 (CD45.2 ϩ ) and B6.SJL-Ptprca Pep3b/BoyJ (CD45.2 Ϫ ) mice were purchased from The Jackson Laboratory. Mice (6-12 wk) were anesthetized by i.p. injection with 2,2,2 tribromoethanol and infected intranasally with 250 50% egg infectious doses (EID 50 ) of Sendai virus or 300 EID 50 of x31 influenza virus for primary infections and with 3,000 EID 50 of PR8 for secondary infections.
Cell Lines and Culture Conditions. JAWS II, an immature dendritic cell line (American Type Culture Collection CLR-11904), was grown in media containing 5 ng/ml rmGM-CSF. AM11 cells, a retrovirally transformed B6 alveolar macrophage line provided by Dr. Bill Walker (St. Jude's Children's Research Hospital, Memphis, TN) were grown as described previously (18) . The T cell thymoma (EL4) and L929/D b cells were grown as described previously (19) . L cells transected with the D b MHC genes have been described previously (20) . The BWZ.36 fusion partner (21) was a gift of Dr. Nilabh Shastri (University of California, Berkeley, CA). For in vitro infections, the cells were infected with influenza virus, then irradiated at 3,000 rads.
Tissue Preparation. Lymphocytes were collected from the broncho-alveolar lavage (BAL), spleens, lung, and mediastinal lymph nodes (MLNs) * as described previously (3) . Dendritic cells and macrophages were isolated from 5 mm pieces of lungs and spleens that were incubated with 5 ml of a 5 mg/ml stock of Collagenase D (Roche). After digestion, the cells were washed and depleted of erythrocytes. For the isolation of epithelial cells, the lungs were digested and the B and T lymphocytes were removed by panning on goat anti-rat IgG coated flasks followed by complement-mediated cytotoxicity (22) (23) (24) .
MHC Tetramer Reagents and Analysis. MHC class I peptide tetramers specific for NP 366-374 /D b and PA 224-233 /D b were generated by the Molecular Biology Core Facility at the Trudeau Institute as described previously (25) . Tetramer staining was performed for 1 h at room temperature, followed by incubation with anti-CD8-PerCP, and 200,000 events were collected on a Becton Dickinson FACSCalibur™ flow cytometer. Data was analyzed using FlowJo (TreeStar) software.
Cell Sorting and Adoptive Transfer. For isolation of dendritic cells and macrophages, cells were stained with anti-CD45R-CyChrome (B220), anti-CD11c-FITC, and anti-CD11b-PE. Samples were then sorted on a FACSVantage™ flow cytometer with DiVa options into B220 Ϫ CD11b ϩ CD11c Ϫ (predominantly macrophages) and B220 Ϫ CD11b ϩ / Ϫ CD11c ϩ (predominantly dendritic cell) populations. For isolation of memory cells, spleen cells were stained with anti-CD8-PE and anti-CD44-FITC and sorted into a purified CD8 ϩ CD44 ϩ (memory) population. The purity after sorting was 95% or greater. Isolated dendritic cells and macrophages were used in an antigen presentation assay and purified memory cells (2.3 ϫ 10 5 ) were injected i.v. into naive B6.SJL-Ptprca Pep3b/BoyJ mice.
Generation of LacZ-inducible T Cell Hybridomas. Splenocytes were harvested from C57BL/6 mice 28 d after intranasal challenge with A/HK-x31. 30 ϫ 10 6 immune splenocytes were cultured with 30 ϫ 10 6 irradiated (3,000 rad) peptide pulsed (1 M specific peptide) syngeneic splenocytes for 5 d. Blast cells were enriched by Ficoll and then fused with BWZ.36 cells (26, 27) . Resulting hybrids were stained for TCR ␤ expression and TCR-␤ hi hybrids were cloned by single cell sorting using a MoFlo (DakoCytomation). The resulting clones were tested for specificity using peptide-pulsed L cells transected with the D b MHC genes. Influenza virus peptides (NP 366-374 , PA 224-233 , PB1 [703] [704] [705] [706] [707] [708] [709] [710] [711] , and HA 192-207 ) were purchased from New England Peptide Inc. and peptide purity was evaluated using reverse-phase HPLC analysis.
Antigen Presentation Assays. Antigen presentation assays were performed as described previously (21, (27) (28) (29) . Briefly, hybridomas (10 5 ) were cultured with virus-infected or peptide-pulsed cells in flat-bottomed microtiter plates. The plates were incubated overnight, washed with PBS and fixed with ␤ -galactosidase fixative (2% formaldehyde/0.2% glutaraldehyde). Cells were washed again with PBS followed by the addition of 50 l of a 1 mg/ml X-gal solution (5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 2 mM magnesium chloride). After 4 h, the hybridomas were examined under a light microscope for the presence of blue cells.
Bone Marrow-derived Dendritic Cells. Bone marrow was flushed from the legs of C57BL/6 mice, depleted of erythrocytes, and 2 ϫ 10 6 lymphocytes were placed into a bacteriological Petri dish with media supplemented with 20 ng/ml recombinant murine granulocyte/monocyte colony-stimulating factor (rmGM-CSF; PeproTech) and incubated at 37 Њ C with 10% CO 2 (30) . On day 3, an additional 10 ml of CTM containing 20 ng/ml rmGM-CSF was added. On days 6 and 8, half of the cells were removed, centrifuged, and added back to the same plate in 10 ml of fresh media containing 20 ng/ml rmGM-CSF. On day 10 of the culture, the cells were used either in antigen presentation assays or 401
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for dendritic cell vaccination (30) . For vaccination, the cells were resuspended at 5 ϫ 10 6 /ml and incubated at 37 Њ C for 3 h with peptide at a concentration of 50 g/ml (31) . After pulsing, the dendritic cells were washed and injected i.v. into mice at a final concentration of 0.5 ϫ 10 6 per mouse. Indeed, the number of memory cells specific for each epitope were the same in the lungs, MLN, and spleen at the time of secondary infection, as determined by tetramer staining and ELISPOT analysis ‫000,11ف(‬ in the lungs, 8,000 in the MLN, and 80,000 in the spleen, data not depicted). Both populations of memory T cells were also indistinguishable on the basis of phenotype (using the CD44, CD43, Fas, NKG2, CD62L, CD11a markers), cytolytic activity, and ability to proliferate in vitro after restimulation (unpublished data). There were also no functional differences between NP 366-374 /D b and PA 224-233 /D b -specific effector T cells generated in either the primary or secondary T cell responses (unpublished data, 15, 16) .
Results

Changing
Changing Patterns of Immunodominance Are Not Dependent on Virus Strain, Dose, or Prior Infection. To determine whether the change in T cell dominance during primary and secondary infections reflected intrinsic differences between the x31 and PR8 influenza virus strains, we reversed the order of viral infections (PR8 followed by x31). As 
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Impact of Differential Antigen Processing on CD8 ϩ T Cells shown in Table I , the pattern of NP 366-374 /D b and PA 224-233 / D b immunodominance in C57BL/6 mice was independent of the strain of virus used. Similar patterns were also obtained when antibody-deficient MT mice were infected twice with the same virus (unpublished data). The changing patterns of immunodominance were also not due to a nonspecific conditioning of the lung by a prior infection (32) . Thus, the ratio of NP 366-374 /D b -and PA 224-233 / D b -specific T cells after x31 infection in mice that had recovered from a heterologous intranasal Sendai virus infection was similar to that of a primary x31 infection (Table I) . As Sendai virus and influenza virus induce very similar inflammatory responses in the lung, this suggests that changes in lung structure and cellular composition induced by a relatively recent respiratory virus infection do not affect the immunodominance of the subsequent T cell response to influenza virus. In addition, the changing patterns of immunodominance do not reflect differences in the inoculating dose of virus. Infection with different virus doses altered the magnitude, but not the composition of the T cell responses (unpublished data). Rather, the immunodominance of the T cell response depends simply on whether the response is primary or secondary in nature. (15, 16, 33) . To address this question, we generated panels of T cell hybridomas specific for the NP 366-374 /D b and PA 224-233 /D b epitopes that could be used as probes for detecting the presentation of these epitopes. The hybridomas were generated by fusion with BWZ.36, which contains the Lac Z reporter gene under the control of the NFAT element of the IL-2 enhancer (21, (27) (28) (29) . TCR mediated recognition of the relevant antigen by the hybridoma results in ␤-galactosidase production, which is detected using an X-gal assay. The advantage of LacZ hybridomas is that they are independent of costimulatory requirements and provide a highly sensitive readout for assessing antigen presentation ex vivo. Fig. 2 shows the specificity and sensitivity of two hybridomas that were selected for further studies. Using these hybridomas, we analyzed NP 366-374 /D b -and PA 224-233 /D bpresentation on H-2 b cell lines that had been infected in vitro with various doses of either x31 or PR8 influenza virus. These included EL4 (a C57BL/6 derived T cell thymoma), AM11 (a C57BL/6 derived alveolar macrophage line), and JAWS II (an immature C57BL/6 dendritic cell line). Uninfected cell lines were used as negative controls. As shown in These data suggested that there was an intrinsic difference in the array of antigens presented by dendritic and nondendritic cells. However, we first considered and excluded several alternative explanations for these data. First, the failure of the nondendritic cell lines to express the PA 224-233 /D b epitope did not appear to be due to inefficient infection of the cells as the NP 366-374 /D b epitope was strongly presented by these cell lines. Second, the difference in antigen presentation was also not hybridoma clone dependent, as the same results were obtained with several other NP 366-374 /D b -and PA 224-233 /D b -specific hybridomas (unpublished data). Third, the difference in antigen presentation could not be explained by a fundamental inability of the nondendritic cell lines to present PA 224-233 /D b to the hybridomas or to low levels of class I molecules since both dendritic and nondendritic cells efficiently presented exogenously added PA 224-233 peptide (Fig. 2) . Fourth, the difference in antigen presentation was not virus strain specific nor dose-dependent since virtually identical results were obtained when the cell lines were infected with different doses of the PR8 virus (Fig. 3) . Fifth, the failure of nondendritic cell lines to present the PA 224-233 /D b epitope did not simply reflect differences in the kinetics of infection and antigen presentation (Figs. 4 and 5) . Furthermore, we saw no detectable differences in cell viability after infection of either the macrophage (AM11) or dendritic (JAWS II) cell line (unpublished data). Finally, we considered the possibility that the pattern of NP 366-374 /D b and PA 224-233 /D b epitope expression in immortalized cell lines was not representative of cells in vivo. To address this issue, we isolated peritoneal macrophages, flow cytometrically sorted splenic B cells, and preparations of lung epithelial cells directly from mice (22, 23, 34) . We also generated dendritic cells from the bone marrow of C57BL/6 mice by culturing the cells according to standard protocols (30, 31) . These cells were then infected with x31 or PR8 in vitro and assayed for antigen presentation using the hybridomas. As shown in 
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The fact that there appeared to be different frequencies of cells expressing the PA 224-233 /D b and NP 366-374 /D b epitopes in vivo was consistent with the in vitro data suggesting that these antigens might be expressed on different subsets of cells. Thus, we analyzed the presentation of the NP 366-374 /D b and PA 224-233 /D b epitopes by different cell subsets after in vivo infection. C57BL/6 mice were intranasally infected with x31 and total lung tissue was isolated 6 d later. The cells were then stained with antibodies specific for B220, CD11b, and CD11c and then sorted by flow cytometry into predominantly macrophage (B220 Ϫ CD11b ϩ CD11c Ϫ ) and predominantly dendritic cell (B220 Ϫ CD11b ϩ/Ϫ CD11c ϩ ) populations (Fig. 7 B) . Purified cells were then analyzed for PA 224-233 /D b and NP 366-374 /D b expression using the hybridoma assay. As shown in Fig. 7 B, the B220 Ϫ CD11b ϩ CD11c Ϫ cells appeared to exclusively express the NP 366-374 /D b epitope, whereas the cells B220 Ϫ CD11b ϩ/Ϫ CD11c ϩ (predominantly dendritic cells) expressed both the PA 224-233 /D b and NP 366-374 /D b epitopes. These data were consistent with the in vitro infection studies and suggest that cell subpopulations differ in their expression of influenza virus antigens.
Naive and Memory T Cells Differ in Their Capacity to Detect Antigen Presented by Different Types of Antigen-presenting
Cells. Based on the previous data, we speculated that differences in the specificity of the primary and secondary (memory) T cell responses to influenza virus might be regulated by differences in the capacity of naive and memory T cells to detect antigen presented by dendritic versus nondendritic cells. . An alternative hypothesis is that the primary infection induces a fundamental change in the characteristics, distribution, or numbers of antigen presenting cells and it is this change that affects the specificity of the secondary (memory) T cell response. To distinguish these possibilities, we used a transfer model to compare the specificity of concurrent naive and memory T cell responses to influenza virus infection in the same animal (33, 35) . This approach allowed us to compare naive and memory T cell responses under conditions that excluded differences in antigen handling. Thus, 2. As these distinct responses occurred in the same animals, these data rule out the possibility that changes in the characteristics, distribution, or numbers of antigen-presenting cells between primary and secondary infections regulate the specificity of the T cell response. Rather, the differences reflect the differential capacity of naive and memory T cells to detect antigen on different sets of antigen-presenting cells. Taken together these data indicate that the dominance of the NP 366-374 /D b response during a secondary infection is regulated by differential antigen presentation by dendritic and nondendritic cells as well as the differential capacity of these cell types to activate naive and memory CD8 ϩ T cells. (36) . Based on previous vaccination studies ( 19) , we hypothesized that mice primed with the PA 224-233 peptide would mediate a response to influenza biased toward nonprotective PA 224-233 / D b -specific T cells resulting in poor viral clearance. To test this hypothesis, we vaccinated mice with dendritic cells pulsed with either the PA 224-233 peptide or a control Sendai virus peptide. 2 wk after dendritic cell vaccination, the mice were infected with 300 50% egg infectious dose (EID 50 ) x31 and the number of tetramer positive cells and viral load was determined on day 10 after infection. As shown in Fig. 9 A, vaccination with PA 224-233 pulsed dendritic cells resulted in a significant increase in the frequency of PA 224-233 /D b -specific T cells (61.7% in vaccinated versus 13.9% in controls) and a significant reduction in the frequency of NP 366-374 /D b specific T cells (4.7% in vaccinated versus 9.1% in controls) in the lung airways. Despite the fact that PA 224-233 peptide vaccinated mice made an enhanced PA 224-233 /D b -specific T cell response to influenza virus infection, they were less effective at clearing the virus. Vaccinated mice were still harboring virus at day 10 post infection whereas control mice had completely cleared virus at this time (Fig. 9 B) . These data indicate that vaccination with peptide defining epitopes expressed exclusively on dendritic cells (and not at the site of infection) can have a negative impact on antiviral immunity. 
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Discussion
We have investigated the mechanisms underlying the changing contributions of NP 366-374 /D b -and PA 224-233 /D bspecific T cells to the primary and secondary response to influenza virus infection in C57BL/6 mice (15, 16) . The data show that the dominance of NP 366-374 /D b -specific T cells in the secondary response cannot be attributed to the virus strain, nonspecific conditioning of the lungs after viral infection, or permanent changes in the characteristics, distribution, or numbers of antigen presenting cells after the primary infection. Rather, the specificity of the T cell response in this system is regulated by differences in the presentation of the NP 366-374 /D b and PA 224-233 /D b epitopes by dendritic and nondendritic cells and the capacity of naive and memory CD8 ϩ T cells to be activated by these cells. Based on these data, we speculate that the change in the specificity of the T cell response reflects the capacity of memory T cells (in contrast to naive T cells) to respond to nondendritic cells (Fig. 10) . During a primary infection, naive T cells can only be activated by dendritic cells (4, (37) (38) (39) . (Fig. 1) . The model also predicts that the specificity of the T cell response is independent of conditioning or alteration of the antigen-presenting cell pool by prior infection. In support of this, both primary and secondary patterns of T cell specificity were simultaneously induced in a transfer model in which the host and its antigen presenting cells were naive with respect to influenza virus infection. Finally, the model predicts that memory T cell responses to the PA 224-233 /D b epitope should be poorly competitive with all epitopes that are expressed on both dendritic and nondendritic cells (such as NP 366-374 /D b ). Indeed, recent studies using influenza virus mutants that lack the NP 366-374 /D b epitope but contain other class I-restricted epitopes indicate that the PA 224-233 /D b -specific responses are not amplified after secondary viral infection (15, 40) . Thus, taken together, the data indicate that differential antigen presentation by dendritic and nondendritic cells and the capacity of the T cells to perceive the antigens presented by these cells regulate the patterns of T cell specificity in this system (Fig. 10) .
A surprising feature of these studies is the observation that antigen-specific T cells can be elicited during a primary response that are potentially unable to recognize antigen at the site of infection. The failure to detect the PA 224-233 / D b antigen on infected lung epithelial cells is of particular interest, as T cell lysis of the epithelial layer is believed to be required for effective viral control (36) . Why might ineffective cells be generated in an infection? One possibility is that dendritic cells are simply superior presenting cells compared with other cell types and that PA 224-233 /D b presentation to T cells is just above a threshold in dendritic, but not nondendritic cells. Enhanced presentation of epitopes by dendritic cells would normally benefit the response by ensuring optimal activation of antigen-specific T cells. However, a negative consequence might be that weakly presented epitopes result in the induction of T cells that are not able to recognize antigen at the site of infection. The idea that ineffective T cells might be generated during an influenza virus infection has important implica- 
408
Impact of Differential Antigen Processing on CD8 ϩ T Cells tions for the development of peptide-based vaccines designed to promote cellular immunity. The choice of relevant epitopes is usually made based on data regarding responses to natural infection. However, some epitopes identified in this manner might actually be detrimental in terms of their ability to elicit protective immunity if the epitope targeted were inadequately expressed at the site of infection. Indeed, in the current studies, the specific priming of PA 224-233 /D b -specific T cells by vaccination actually resulted in impaired clearance of a subsequent influenza virus infection (Fig. 9) . In this situation, we speculate that primed (memory) PA 224 (19) . Clearly the selection of appropriate epitopes for vaccination must take into account the pattern of antigen presentation on different cell types.
A critical question raised by these studies is the frequency with which differential antigen presentation might affect the specificity of T cell responses. Several recent studies suggest that this may be a very frequent occurrence. Furthermore, when LCMV infected fibroblasts or dendritic cells were used to restimulate CTLs, the resulting CTL lines differentially presented the same epitopes (41) . In addition, following HSV infection the primary CTL response to two immunodominant epitopes (gB 498-505 and ICP27 [445] [446] [447] [448] [449] [450] [451] [452] ) have similar kinetics and precursor frequencies. After reinfection, CTLs specific for the ICP27 [445] [446] [447] [448] [449] [450] [451] [452] epitope are present at higher frequencies than CTLs specific for the gB 498-505 epitope (42) .
There are several possible mechanisms that would explain the differential antigen processing by dendritic and nondendritic cells after influenza virus infection. One possibility is that it depends on the degree of infection established in the antigen-presenting cells. It has previously been shown that whereas ‫%09ف‬ of both dendritic cells and macrophages can be infected with influenza virus, the infection in dendritic cells does not result in cell death and few progeny virions are produced (43, 44) . In contrast, macrophages die within 10-12 h after infection and produce 10-fold higher progeny than dendritic cells (43) . However, increased levels of virus in macrophages would tend to favor the processing of both antigens, whereas the data show that macrophages fail to present detectable levels of the PA 224 Taken together, the data in this report show that differential antigen presentation by dendritic and nondendritic T cells can have a significant impact on the specificity of the T cell responses. This phenomenon may play a role in determining immunodominance hierarchies and the efficiency of T cell responses at effector sites. Additionally, we have shown that vaccination with an epitope presented predominantly by infected dendritic cells resulted in delayed control of a subsequent viral infection. Understanding the impact of differential antigen processing is therefore essential for the development of effective peptide-based vaccines.
